Amedeo Smart

Free Medical Literature Service


 

Amedeo

Multiple Sclerosis

  Free Subscription

15.08.2022

1 J Neuroimmunol
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
2 J Neurosci
4 Mult Scler
1 Nat Rev Neurol
1 Nervenarzt
3 Neurology



    J Neuroimmunol

  1. KASHEKE GDS, Holman SP, Robertson GS
    Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;370:577926.
    >> Share


    J Neurol

  2. FEINSTEIN A, Amato MP, Brichetto G, Chataway J, et al
    The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study.
    J Neurol. 2022 Aug 8. pii: 10.1007/s00415-022-11295.
    >> Share


    J Neurol Neurosurg Psychiatry

  3. BOSE G, Healy BC, Barro C, Glanz BI, et al
    Younger age at multiple sclerosis onset is associated with worse outcomes at age 50.
    J Neurol Neurosurg Psychiatry. 2022 Aug 11. pii: jnnp-2022-329353.
    >> Share


    J Neurol Sci

  4. HJAERESEN S, Svenningsen AF
    The possible function and regulation of macrophage migration inhibitory factor (MIF) in multiple sclerosis (MS).
    J Neurol Sci. 2022;441:120352.
    >> Share


    J Neurosci

  5. ROCZKOWSKY A, Doan MAL, Hlavay B, Mamik MK, et al
    Peroxisome injury in multiple sclerosis: protective effects of 4-phenylbutyrate in CNS-associated macrophages.
    J Neurosci. 2022 Aug 8. pii: JNEUROSCI.0312-22.2022.
    >> Share

  6. FEINBERG PA, Becker SC, Chung L, Ferrari L, et al
    Elevated TNF-alpha Leads to Neural Circuit Instability in the Absence of Interferon Regulatory Factor 8.
    J Neurosci. 2022;42:6171-6185.
    >> Share


    Mult Scler

  7. BLYAU S, Koubiyr I, Saranathan M, Coupe P, et al
    Differential vulnerability of thalamic nuclei in multiple sclerosis.
    Mult Scler. 2022 Aug 12:13524585221114247. doi: 10.1177/13524585221114247.
    >> Share

  8. CONWAY SE, Pua DKA, Holroyd KB, Galetta K, et al
    Neurologic disease activity in people with multiple sclerosis treated with immune checkpoint inhibitors.
    Mult Scler. 2022 Aug 11:13524585221117949. doi: 10.1177/13524585221117949.
    >> Share

  9. WILLIAMS T, Tur C, Eshaghi A, Doshi A, et al
    Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial.
    Mult Scler. 2022 Aug 9:13524585221114441. doi: 10.1177/13524585221114441.
    >> Share

  10. CIFTCI KAVAKLIOGLU B, Erdman L, Goldenberg A, Kavaklioglu C, et al
    Machine learning classification of multiple sclerosis in children using optical coherence tomography.
    Mult Scler. 2022 Aug 9:13524585221112605. doi: 10.1177/13524585221112605.
    >> Share


    Nat Rev Neurol

  11. CORREALE J, Hohlfeld R, Baranzini SE
    The role of the gut microbiota in multiple sclerosis.
    Nat Rev Neurol. 2022 Aug 5. pii: 10.1038/s41582-022-00697.
    >> Share


    Nervenarzt

  12. WILLISON AG, Meuth SG
    [Multiple sclerosis: interventions to halt disease : Which patients can be considered for autologous stem cell transplantation].
    Nervenarzt. 2022 Aug 11. pii: 10.1007/s00115-022-01358.
    >> Share


    Neurology

  13. DOBSON R, Bove R
    IVF and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk.
    Neurology. 2022 Aug 11. pii: WNL.0000000000201242.
    >> Share

  14. MAINGUY M, Tillaut H, Degremont A, Le Page E, et al
    Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis.
    Neurology. 2022 Aug 11. pii: WNL.0000000000201027.
    >> Share

  15. O'MAHONY J, Salter A, Ciftci B, Fox RJ, et al
    Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis.
    Neurology. 2022 Aug 10. pii: WNL.0000000000200931.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016